NeuBase Therapeutics, Inc.
NeuBase Therapeutics, Inc. is a Private limited company (Ltd.) registered in United States under 6928632, and its current status with Pennsylvania Department of State is active. The company was incorporated on 2 August 2019 and lists its registered address as United States. 5 shareholders are on record for NeuBase Therapeutics, Inc., including at least one natural person recorded as a direct holder; the filing carries no beneficial-ownership flag, so that holder is noted here as a recorded shareholder rather than a confirmed ultimate beneficial owner (UBO). This profile is sourced directly from Pennsylvania Department of State and was last updated on 4 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Five shareholders are currently on record for NeuBase Therapeutics, Inc., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.
The largest of these is Armistice Capital, LLC, holding 27.8% — the largest recorded stake — followed by Greenlight Capital, Inc. at 22.8%; the remaining 3 shareholders shown hold smaller stakes.
The register reports 18 shareholders in total, though only the top 5 by holding are shown in this view.
4 shareholders shown are companies, so the ownership chain continues above this level for those holdings; the other 1 is recorded as direct individual holder, though the record carries no UBO/PSC flag confirming beneficial-owner status.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Armistice Capital, LLC | 27.8% | Pennsylvania Department of State | |
| Greenlight Capital, Inc. | 22.8% | Pennsylvania Department of State | |
| Point72 Asset Management, L.P. | 10.5% | Pennsylvania Department of State | |
| Decheng Capital Management III (Cayman), LLC | 8.4% | Pennsylvania Department of State | |
| Carnegie Mellon University | 7.9% | Pennsylvania Department of State |
Officers
5
The Chairman/ceo/founder of NeuBase Therapeutics, Inc. currently on record is DIETRICH STEPHAN; five officers are currently on record for NeuBase Therapeutics, Inc., filed with Pennsylvania Department of State.
Management authority at NeuBase Therapeutics, Inc. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
NeuBase Therapeutics, Inc. has no recorded parent company — it sits at the top of its own group structure, with 3 subsidiaries recorded beneath it across 1 jurisdiction. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 3 subsidiaries span United States jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
NeuBase Therapeutics, Inc.
United States
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns NeuBase Therapeutics, Inc.?
Five shareholders are currently on record for NeuBase Therapeutics, Inc., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Armistice Capital, LLC, holding 27.8% — the largest recorded stake — followed by Greenlight Capital, Inc. at 22.8%; the remaining 3 shareholders shown hold smaller stakes. 4 shareholders shown are companies, so the ownership chain continues above this level for those holdings; the other 1 is recorded as direct individual holder, though the record carries no UBO/PSC flag confirming beneficial-owner status.
Who is NeuBase Therapeutics, Inc.'s UBO (Ultimate Beneficial Owner)?
At least one shareholder recorded for NeuBase Therapeutics, Inc. is a natural person. The record carries no dedicated UBO/PSC flag, so that holder is stated here as a recorded shareholder rather than a confirmed Ultimate Beneficial Owner (UBO).
How many shareholders does NeuBase Therapeutics, Inc. have on record?
5 shareholders are shown on record for NeuBase Therapeutics, Inc.. The register reports 18 in total; only the top 5 by holding are shown here.
What is NeuBase Therapeutics, Inc.'s company registration number?
NeuBase Therapeutics, Inc.'s registration number is 6928632, filed with Pennsylvania Department of State in United States. Its current status on the register is active.
Is NeuBase Therapeutics, Inc. still an active company?
NeuBase Therapeutics, Inc.'s status on Pennsylvania Department of State is listed as active.
When was NeuBase Therapeutics, Inc. incorporated?
NeuBase Therapeutics, Inc. was incorporated on 2 August 2019, according to Pennsylvania Department of State.
What is NeuBase Therapeutics, Inc.'s registered address?
The registered address on file for NeuBase Therapeutics, Inc. is United States.
What legal structure is NeuBase Therapeutics, Inc. registered as?
NeuBase Therapeutics, Inc. is registered as a Private limited company (Ltd.) in United States.
Who are the officers/directors of NeuBase Therapeutics, Inc.?
The Chairman/ceo/founder of NeuBase Therapeutics, Inc. currently on record is DIETRICH STEPHAN; five officers are currently on record for NeuBase Therapeutics, Inc., filed with Pennsylvania Department of State. Management authority at NeuBase Therapeutics, Inc. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does NeuBase Therapeutics, Inc. have a parent company or subsidiaries?
NeuBase Therapeutics, Inc. has no recorded parent company — it sits at the top of its own group structure, with 3 subsidiaries recorded beneath it across 1 jurisdiction. Those 3 subsidiaries span United States jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Can Zavia monitor changes to NeuBase Therapeutics, Inc.'s ownership over time?
This profile reflects a point-in-time snapshot from Pennsylvania Department of State. Zavia's monitoring API can track changes to NeuBase Therapeutics, Inc.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access NeuBase Therapeutics, Inc.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like NeuBase Therapeutics, Inc.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Pennsylvania Department of State and was last synced on 4 October 2026.